Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Diabetes Care
|
June 24, 2021
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
Vibha Anand, Ying Li, Bin Liu, et al.
The Journal of Clinical Investigation
|
October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
Katharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Diabetes/Metabolism Research and Reviews
|
February 20, 2024
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
A Emile J Hendriks, M Loredana Marcovecchio, Rachel E J Besser, et al.
Ebiomedicine
|
May 9, 2024
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
Alexander Lind, Eva Freyhult, Felipe de Jesus Cortez, et al.
Journal of the Endocrine Society
|
June 11, 2025
β-Cell Function and Glucose Tolerance in Persons With Multiple Islet Autoantibodies Randomized to a Gluten-free Diet
Marlena Maziarz, Jaakko J Koskenniemi, Maria Månsson Martinez, et al.
BMC Pediatrics
|
May 18, 2017
Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity
Markus Lundgren, Leigh Johnson Steed, Roy Tamura, et al.
Diabetologia
|
January 12, 2024
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
Sandra Hummel, Sarah Rosenberger, Thekla von dem Berge, et al.
Lancet (London, England)
|
November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial
Anette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
JAMA
|
September 8, 2023
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
Marija Lugar, Anne Eugster, Peter Achenbach, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
July 1, 2026
Determinants of Infant Participation and Non-Participation in Primary Prevention Trials
Franziska Wörl, Peter Achenbach, Ezio Bonifacio, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Diabetes Care
|
June 24, 2021
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
Vibha Anand, Ying Li, Bin Liu, et al.
The Journal of Clinical Investigation
|
October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
Katharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Diabetes/Metabolism Research and Reviews
|
February 20, 2024
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
A Emile J Hendriks, M Loredana Marcovecchio, Rachel E J Besser, et al.
Ebiomedicine
|
May 9, 2024
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
Alexander Lind, Eva Freyhult, Felipe de Jesus Cortez, et al.
Journal of the Endocrine Society
|
June 11, 2025
β-Cell Function and Glucose Tolerance in Persons With Multiple Islet Autoantibodies Randomized to a Gluten-free Diet
Marlena Maziarz, Jaakko J Koskenniemi, Maria Månsson Martinez, et al.
BMC Pediatrics
|
May 18, 2017
Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity
Markus Lundgren, Leigh Johnson Steed, Roy Tamura, et al.
Diabetologia
|
January 12, 2024
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
Sandra Hummel, Sarah Rosenberger, Thekla von dem Berge, et al.
Lancet (London, England)
|
November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial
Anette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
JAMA
|
September 8, 2023
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
Marija Lugar, Anne Eugster, Peter Achenbach, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
July 1, 2026
Determinants of Infant Participation and Non-Participation in Primary Prevention Trials
Franziska Wörl, Peter Achenbach, Ezio Bonifacio, et al.
Page
of 7